Resultados de la búsqueda

Martin P, Blanco-Dominguez R, Sanchez-Diaz R Novel human immunomodulatory T cell receptors and their double-edged potential in autoimmunity, cardiovascular disease and cancer Cell Mol Immunol (2020) 18:919-35

Tsilingiri K, de la Fuente H, Relano M, Sanchez-Diaz R, Rodriguez C, Crespo J, Sanchez-Cabo F, Dopazo A, Alonso-Lebrero JL, Vara A, Vazquez J, Casasnovas JM, Alfonso F, Ibanez B, Fuster V, Martinez-Gonzalez J, Martin P*, Sanchez-Madrid F*. (PM and FSM are co-corresponding authors) oxLDL Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease. Circulation (2019) 139:243-55
Link to the full text in Repisalud

Viswanath P, Radoul M, Izquierdo-Garcia JL, Luchman HA, Gregory Cairncross J, Pieper RO, Phillips JJ, Ronen SM. Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner. Cancer Metab (2018) 6:3
Link to the full text in Repisalud

Sánchez-Díaz R, Blanco-Dominguez R, Lasarte S, Tsilingiri K, Martín-Gayo E, Linillos-Pradillo B, de la Fuente H, Sánchez-Madrid F, Nakagawa R, Toribio ML, Martín P. Thymus-derived Treg cell development is regulated by C-type-lectin–mediated BIC/miRNA155 expression. Mol Cell Biol (2017) 37:e00341-16
Link to the full text in Repisalud

Rodriguez A, Garaulet G, Lazcano JJ, Alarcon H, de Frutos S, Martinez-Torrecuadrada JL. Display of the albumin binding domain in the envelope improves lentiviral vector bioavailability. Hum Gene Ther Methods (2017) 28:340-51

Tsilingiri K, Fornasa G, Rescigno M. Thymic Stromal Lymphopoietin: To Cut a Long Story Short. Cell Mol Gastroenterol Hepatol (2017) 3:174-82
Link to the full text in Repisalud

Cibrian D, Saiz ML, de la Fuente H, Sanchez-Diaz R, Moreno-Gonzalo O, Jorge I, Ferrarini A, Vazquez J, Punzon C, Fresno M, Vicente-Manzanares M, Dauden E, Fernandez-Salguero PM, Martin P, Sanchez-Madrid F. CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. Nat Immunol (2016) 17:985-96

Liappas G*, Gonzalez-Mateo GT*, Sanchez-Diaz R*, Lazcano JJ, Lasarte S, Matesanz-Marin A, Zur R, Ferrantelli E, Ramirez LG, Aguilera A, Fernandez-Ruiz E, Beelen RH, Selgas R, Sanchez-Madrid F, Martin P*, Lopez-Cabrera M*. (GL, GTGM and RSD contributed equally and PM and MLC are co-corresponding authors) Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis. J Am Soc Nephrol (2016) 27:3561-76

Barreiro O, Cibrian D, Clemente C, Alvarez D, Moreno V, Valiente I, Bernad A, Vestweber D, Arroyo AG, Martin P, Andrian UV, Sanchez Madrid F. Pivotal role for skin trans-endothelial radio-resistant anti-inflammatory macrophages in tissue repair. eLife (2016) 5:e15251
Link to the full text in Repisalud

Borroto A, Reyes-Garau D, Jimenez MA, Carrasco E, Moreno B, Martinez-Pasamar S, Cortes JR, Perona A, Abia D, Blanco S, Fuentes M, Arellano I, Lobo J, Heidarieh H, Rueda J, Esteve P, Cibrian D, Martinez-Riano A, Mendoza P, Prieto C, Calleja E, Oeste CL, Orfao A, Fresno M, Sanchez-Madrid F, Alcami A, Bovolenta P, Martin P, Villoslada P, Morreale A, Messeguer A, Alarcon B. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases. Sci Transl Med (2016) 8:ra184